Nexcida Therapeutics
Menlo Park
About Nexcida Therapeutics
Nexcida Therapeutics develops a novel antibiotics to treat serious, life-threatening bacterial infections. The company is led by an outstanding team of proven anti-infectives drug developers and is committed to addressing the emerging threat of drug-resistant bacteria. Nexcida Therapeutics was founded in 2014 and is based in Menlo Park, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $2.8M
- Last round: Series Unknown (Jun 2015)
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science
Canonical: https://fsome.com/organization/nexcida-therapeutics-2672091 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.